Brillient Corporation Wins $49 Million FDA Contract

The Food and Drug Administration (FDA) awarded a $49 million contract to Reston, Virginia-based Brillient Corp.* to provide professional and technical services. The contract is a single award Blanket Purchase Agreement (BPA) with a five-year performance period (including options). "As FDA undertakes new scientific and consumer safety initiatives, the Brillient team will provide expertise in the areas of program evaluation, policy development, strategic communications, budget/financial management, as well as overarching program and project management support," the company said. *Small business